JP2016528165A5 - - Google Patents

Download PDF

Info

Publication number
JP2016528165A5
JP2016528165A5 JP2016509176A JP2016509176A JP2016528165A5 JP 2016528165 A5 JP2016528165 A5 JP 2016528165A5 JP 2016509176 A JP2016509176 A JP 2016509176A JP 2016509176 A JP2016509176 A JP 2016509176A JP 2016528165 A5 JP2016528165 A5 JP 2016528165A5
Authority
JP
Japan
Prior art keywords
hydroxy
alkyl
aliphatic hydrocarbon
composition according
cyclo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016509176A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016528165A (ja
JP6641263B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2014/072508 external-priority patent/WO2015025980A1/en
Publication of JP2016528165A publication Critical patent/JP2016528165A/ja
Publication of JP2016528165A5 publication Critical patent/JP2016528165A5/ja
Application granted granted Critical
Publication of JP6641263B2 publication Critical patent/JP6641263B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016509176A 2013-08-22 2014-08-21 神経障害性疼痛の処置方法 Expired - Fee Related JP6641263B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361868750P 2013-08-22 2013-08-22
US61/868,750 2013-08-22
US201361918124P 2013-12-19 2013-12-19
US61/918,124 2013-12-19
PCT/JP2014/072508 WO2015025980A1 (en) 2013-08-22 2014-08-21 Method for treating neuropathic pain

Publications (3)

Publication Number Publication Date
JP2016528165A JP2016528165A (ja) 2016-09-15
JP2016528165A5 true JP2016528165A5 (enExample) 2017-09-28
JP6641263B2 JP6641263B2 (ja) 2020-02-05

Family

ID=52480928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016509176A Expired - Fee Related JP6641263B2 (ja) 2013-08-22 2014-08-21 神経障害性疼痛の処置方法

Country Status (4)

Country Link
US (1) US20150057351A1 (enExample)
EP (1) EP3035925A4 (enExample)
JP (1) JP6641263B2 (enExample)
WO (1) WO2015025980A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180058758A (ko) 2015-09-22 2018-06-01 그레이버그 비젼, 인크. 안구 장애의 치료를 위한 화합물 및 조성물
IL266448B2 (en) * 2017-01-06 2023-11-01 Clexio Biosciences Ltd Topical datumidine formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
TW224942B (enExample) 1990-04-04 1994-06-11 Adka Ueno Kk
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
WO1997047595A1 (en) 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Endothelin antagonist
PL365701A1 (en) * 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MXPA03007487A (es) * 2001-02-22 2003-12-08 Ono Pharmaceutical Co Composicion medicinal que comprende diclofenaco y ornoprostil.
MXPA04002006A (es) * 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
WO2005115392A2 (en) * 2004-05-11 2005-12-08 Incyte Corporation 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
KR101623205B1 (ko) * 2005-03-04 2016-05-20 수캄포 아게 말초 혈관 질환 치료를 위한 방법 및 조성물
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
KR20100038061A (ko) * 2008-10-02 2010-04-12 도쿠리츠다이가쿠호징 가나자와다이가쿠 리마프로스트를 함유하는, 암화학 요법에 기인하는 말초신경장애 예방, 치료 및/또는 증상 경감제
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
CN107903173A (zh) * 2011-08-05 2018-04-13 苏坎波公司 治疗精神分裂症的方法

Similar Documents

Publication Publication Date Title
JP2014505660A5 (enExample)
AU2015293541B2 (en) Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof
JP2015518491A5 (enExample)
IN2014MN02106A (enExample)
WO2013121449A8 (en) Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases
AR072990A1 (es) Compuestos de tetraciclina sustituidos con fluor en c7
JP2016511753A5 (enExample)
HRP20151397T1 (hr) DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE
AR083760A1 (es) Agentes antibacterianos y composiciones farmaceuticas
JP2011527345A5 (enExample)
JP2015508092A5 (enExample)
NZ721645A (en) Compounds for use as gpr120 agonists
JP2013518036A5 (enExample)
RU2014118123A (ru) Энантиомеры-2-гидроксипроизводных жирных кислот
WO2011100502A8 (en) 7-aminofuropyridine derivatives
JP2004527567A5 (enExample)
RU2012146325A (ru) Терапевтическое средство или профилактическое средство для лечения фибромиалгии
RU2013136895A (ru) Новое бициклическое соединение или его соль
RU2018113296A (ru) Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение и способ стабилизации этого соединения
JP2014511825A5 (enExample)
MX2019003470A (es) Composicion farmaceutica y metodo para el tratamiento de la enfermedad del higado graso no alcoholico.
JP2016528165A5 (enExample)
JP2010533707A5 (enExample)
AR076516A1 (es) Derivados de oxa-azaespiro[3.3]heptan-6-ilo, metodo e intermediarios para su preparacion, composiciones farmaceuticas que los comprenden y su uso en el tratamiento de enfermedades mediadas por el receptor mch1.
JP2008528440A5 (enExample)